Canton Strategic Holdings (CNTN) Cash from Operations (2021 - 2026)
Canton Strategic Holdings (CNTN) reported Cash from Operations of 7635188.0 for Q1 2026, down 183.94% on a YoY basis from 9095851.28 in Q1 2025, and up 26.88% quarter-over-quarter from 10441616.0 in Q4 2025.
Canton Strategic Holdings (CNTN) Cash from Operations (2021 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Cash from Operations for 6 years, with the latest figure at 7635188.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 183.94% year-over-year to 7635188.0; the trailing twelve-month figure through Mar 2026 stood at 21074503.0 (down 95.79% YoY), and the FY2025 full-year result was 16128316.0, down 47.97% from the prior year.
- Cash from Operations for Q1 2026 stood at 7635188.0, up from 10441616.0 in the prior quarter.
- The five-year high for Cash from Operations was 892676.0 in Q4 2022, with the low at 10441616.0 in Q4 2025.
- Historically, Cash from Operations has averaged 2854209.41 across 5 years, with a median of 2179303.0 in 2024.
- Annual changes were most pronounced in 2022 — Cash from Operations plunged 11530.96% — and 2025, when it soared 47.57%.
- Canton Strategic Holdings' Cash from Operations stood at 892676.0 in 2022, then slumped by 58.56% to 1415427.0 in 2023, then plunged by 114.19% to 3031656.0 in 2024, then slumped by 244.42% to 10441616.0 in 2025, then increased by 26.88% to 7635188.0 in 2026.
- The last three Cash from Operations figures came in at 7635188.0 (Q1 2026), 10441616.0 (Q4 2025), and 1855169.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | -7.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.64 Mn |
| Mar 31, 2026 | -7.64 Mn |
| Dec 31, 2025 | -10.44 Mn |
| Dec 31, 2025 | -10.44 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | -1.14 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Dec 31, 2024 | -3.03 Mn |
| Dec 31, 2024 | -3.03 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Mar 31, 2024 | -2.83 Mn |
| Mar 31, 2024 | -2.83 Mn |
| Dec 31, 2023 | -1.42 Mn |
| Dec 31, 2023 | -1.42 Mn |